Volume 13, Number 1—January 2007
Research
Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England
Table 2
Estimated coverage of measles, mumps, rubella vaccine at 2 and 5 years of age by area and birth cohort
Birth cohort* | % Coverage at 2 years of age | % Coverage at 5 years of age | ||||
---|---|---|---|---|---|---|
Outside London | London | Outside London | London | |||
1 dose | 1 dose | >1 dose | 2 doses | >1 dose | 2 doses | |
1993–1994 | 92.7 | 77.1 | 95.7 | 78.1 | 88.6 | 57.1 |
1994–1995 | 92.0 | 76.6 | 95.0 | 78.3 | 87.9 | 56.3 |
1995–1996 | 91.9 | 76.0 | 94.9 | 76.4 | 85.0 | 59.6 |
1996–1997 | 90.4 | 73.3 | 93.4 | 76.7 | 84.5 | 58.0 |
1997–1998 | 88.8 | 69.7 | 92.0 | 76.8 | 82.9 | 56.8 |
1998–1999 | 89.0 | 69.5 | 92.3 | 77.6 | 81.3 | 56.3 |
1999–2000 | 86.9 | 65.8 | 91.3 | 77.3 | 80.1 | 56.8 |
2000–2001 | 85.3 | 64.5 | 90.1 | 76.4 | 78.9 | 55.8 |
2001–2002 | 80.6 | 59.4 | – | – | – | – |
2002–2003 | 82.7 | 60.3 | – | – | – | – |
*Birth cohorts for school year (i.e., children born October 1–September 30 of the following year).
1Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa